Total Mesorectal Excision for Rectal Cancer: What Defines a Quality Resection
PG Colon Course – Christopher Schlachta disclosures–39 sec rectal cx therapy–43 sec TME–8:03 macroscopic eval–9:33 video clip–11:05 reconstruction–13:30 defunctioning–14:00 summary–14:21 Keyword(s): ED, LAR, local recurrence, mesorectum, QOL, rectal cx, sphincter preserving, TME
Emerging Technology in the Diagnosis of Barrett’s Esophagus: Blair Jobe, M.D.
Barrett’s Debate: How to Follow, How to Treat? citations–1:35 https://www.ncbi.nlm.nih.gov/pubmed/?term=11781277 BERC–2:41 goals of novel imaging methods–7:13 magnification endoscopy–7:53 NBI–8:22 citations–8:37 https://www.ncbi.nlm.nih.g Keyword(s): AFE, BE, BERC, confocal endomicroscopy, EAC, emerging technology, EMR, endoscopic transplant, endoscopy, epithelial cell sheets, ESD, esophageal strictures, esophageal ulcers, extracellular matrix, GERD, HGD, indigo carmine, magnification endoscopy, NBI, OCT, proteomics, screening, sensitivity, […]
Limited Surgical Resection – or En-Bloc: Karl H. Fuchs, M.D.
Barrett’s Debate: How to Follow, How to Treat? discussion–27 sec citation–2:20 https://www.ncbi.nlm.nih.gov/pubmed/?term=12444180 https://www.ncbi.nlm.nih.gov/pubmed/?term=15483031 https://www.ncbi.nlm.nih Keyword(s): BE, en-bloc esophagectomy, esophageal adenocarcinoma, limited surgical resection, Meredino procedure, mucosal cx, neoadjuvant CRT, nodal micrometastasis, QOL, transhiatal resection, transthoracic resection, TTE, vagal sparing
Endoscopic Mucosal Resection of Early Esophageal Neoplasia: Haruhiro Inoue, M.D.
Barrett’s Debate: How to Follow, How to Treat? terminology–10 sec indications for surgery–1:11 tx options–1:28 EMR kit–2:44 https://www.ncbi.nlm.nih.gov/pubmed/8454147 EMR–2:58 citation–6:04 https://www.ncbi.nlm.nih.gov/pubmed/15452789 E Keyword(s): BE, cap-fitted panendoscope, colon mucosal lesions, EMR, ESD, esophageal cx, EUS, HGD, piecemeal, SCC, stomach, TT knife, TTK
Ablation Therapy – Who Should Have It and Who Should Do It? John Hunter, M.D.
Barrett’s Debate: How to Follow, How to Treat? disclosures–18 sec BE prevalence–54 sec https://www.ncbi.nlm.nih.gov/pubmed/?term=12145799 who should do it?–2:14 who should have it?–2:49 histologic progression of BE–3:29 HGD–4:03 https:// Keyword(s): Barrx, BE, cost-utility analysis, EAC, endoscopic ablative therapy, erosive esophagitis, esophageal adenocarcinoma, esophagectomy, flow cytometry, gastroenterologist, HGD, histology, invasive cx, LGD, metaplasia, NBI, neoadjuvant CRT, nonsurgical […]